EUROPEAN MARKETS FOR DRUG DELIVERY PRODUCTS AND TECHNOLOGIES

455 Pages | 200 Exhibits | 2009 Analysis | Forecasts Through 2013 Product Family: Market Reports




OVERVIEW:
Pharmacotherapy represents the predominant first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in Europe. This report covers oral, transdermal, inhalation, transmucosal, and injectable drug delivery devices. In 2007, European sales of these products totaled approximately $25 billion; over the forecast period covered by this report, sales are expected to increase at a compound annual growth rate of 11.2%, reaching more than $47 billion in the year 2013.

This new report by Medtech Insight presents a detailed overview of the European drug delivery products and technologies market. Major topics covered by this report include an overview of European healthcare markets; an overview of the biomechanics of drug delivery; discussions of drug delivery devices in the oral, transdermal, inhalation, transmucosal, and injectable market segments; and analyses of each of the sales and leading competitors in each of these markets.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. European Market for Oral Drug Delivery Products
	a. Diffusion-Controlled Systems
	b. Solvent-Activated Systems
	c. Chemically Controlled Systems
	d. Regulated Systems
	e. Closed-Loop Systems
	f. Multiparticulate Systems
	g. Technological Advances
	h. Market Analysis
ii. European Market for Transdermal Drug Delivery Products
	a. Single-Layer Drug-in-Adhesive
	b. Multilayer Drug-in-Adhesive
	c. Reservoir
	d. Matrix
	e. Technological Advances
	f. Market Analysis
iii. European Market for Inhalation Drug Delivery Products
	a. Metered Dose Inhalers
	b. Dry Powder Inhalers
	c. Nebulizer Inhalers
	d. Liquid-Based Inhalers
	e. Technological Advances
	f. Market Analysis
iv. European Market for Transmucosal Drug Delivery Products
	a. Buccal/Sublingual
	b. Nasal
	c. Ocular
	d. Vaginal
	e. Market Analysis
v. European Market for Injectable Drug Delivery Products
	a. Injection Drug Delivery Products
	b. Infusion Drug Delivery Products
	c. Market Analysis
vi. Combined Market Analysis

Exhibit ES-1: Europe, Oral Drug Delivery Products, Market Forecast, by Country, 2007-2013
Exhibit ES-2: Europe, Transdermal Drug Delivery Systems, Market Forecast, by Country, 2007-2013
Exhibit ES-3: Europe, Inhalation Drug Delivery Products, Market Forecast, by Country, 2007-2013
Exhibit ES-4: Europe, Transmucosal Drug Delivery Products, Market Forecast, by Country, 2007-2013
Exhibit ES-5: Europe, Injectable Drug Delivery Products, Market Forecast, by Country, 2007-2013
Exhibit ES-6: Europe, Sales of Drug Delivery Products, by Market Segment, 2007 and 2013
Exhibit ES-7: Europe, Drug Delivery Products, Combined Market Forecast, by Country, 2007-2013

1. EUROPEAN HEALTHCARE MARKETS

1.1 The European Union
	1.1.1 A Common Currency
	1.1.2 Regulatory Policies
	1.1.3 Reimbursement
	1.1.4 Healthcare Spending
1.2 Selected European National Healthcare Profiles
	1.2.1 France
		1.2.1.1 Healthcare Organization and Reform
		1.2.1.2 Hospital Services
		1.2.1.3 Medical Device Reimbursement
	1.2.2 Germany
		1.2.2.1 Healthcare Organization and Reform
		1.2.2.2 Hospital Services
		1.2.2.3 Medical Device Reimbursement
	1.2.3 Italy
		1.2.3.1 Healthcare Organization and Reform
		1.2.3.2 Hospital Services
		1.2.3.3 Medical Device Reimbursement
	1.2.4 Spain
		1.2.4.1 Healthcare Organization and Reform
		1.2.4.2 Hospital Services
		1.2.4.3 Medical Device Reimbursement
	1.2.5 United Kingdom
		1.2.5.1 Healthcare Organization and Reform
		1.2.5.2 Hospital Services
		1.2.5.3 Medical Device Reimbursement
	1.2.6 Benelux
		1.2.6.1 Healthcare Organization and Reform
			1.2.6.1.1 Belgium
			1.2.6.1.2 Luxembourg
			1.2.6.1.3 The Netherlands
		1.2.6.2 Hospital Services
		1.2.6.3 Medical Device Reimbursement
	1.2.7 Nordic Countries
		1.2.7.1 Healthcare Organization and Reform
			1.2.7.1.1 Denmark
			1.2.7.1.2 Finland
			1.2.7.1.3 Norway
			1.2.7.1.4 Sweden
		1.2.7.2 Hospital Services
		1.2.7.3 Medical Device Reimbursement

Exhibit 1-1: European Union, Medical Devices Risk Classification System
Exhibit 1-2: European Union Population Statistics Comparison for the Years 1996, 2006, and 2016
Exhibit 1-3: France, Selected National Healthcare Statistics
Exhibit 1-4: Germany, Selected National Healthcare Statistics
Exhibit 1-5: Italy, Selected National Healthcare Statistics
Exhibit 1-6: Spain, Selected National Healthcare Statistics
Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics
Exhibit 1-8: Belgium, Selected National Healthcare Statistics
Exhibit 1-9: Luxembourg, Selected National Healthcare Statistics
Exhibit 1-10: The Netherlands, Selected National Healthcare Statistics
Exhibit 1-11: Denmark, Selected National Healthcare Statistics
Exhibit 1-12: Finland, Selected National Healthcare Statistics
Exhibit 1-13: Norway, Selected National Healthcare Statistics
Exhibit 1-14: Sweden, Selected National Healthcare Statistics

2. OVERVIEW OF DRUG DELIVERY

2.1 Current Developments
2.2 Pharmacokinetics
	2.2.1 Drug Absorption
		2.2.1.1 Transportation Across Cell Membranes
			2.2.1.1.1 Active Transport
			2.2.1.1.2 Facilitated Passive Diffusion
			2.2.1.1.3 Passive Diffusion
			2.2.1.1.4 Pinocytosis
		2.2.1.2 Oral Drug Delivery
		2.2.1.3 Parenteral Drug Delivery
		2.2.1.4 Transdermal Drug Delivery
		2.2.1.5 Inhalation Drug Delivery
	2.2.2 Drug Distribution
	2.2.3 Drug Metabolism
		2.2.3.1 Enzyme Induction
		2.2.3.2 Enzyme Inhibition
		2.2.3.3 Factors Affecting Metabolism
	2.2.4 Drug Elimination
		2.2.4.1 Metabolism
		2.2.4.2 Excretion
2.3 Pharmacodynamics
	2.3.1 Agonists and Antagonists

Exhibit 2-1: Relationship Between Pharmacokinetics and Pharmacodynamics
Exhibit 2-2: Routes for Parenteral Drug Delivery
Exhibit 2-3: Advantages and Disadvantages of Transdermal Drug Delivery
Exhibit 2-4: Biochemical Pathway for Oxidative Drug Metabolism
Exhibit 2-5: Examples of Physiologic and Drug-Receptor Proteins

3. EUROPEAN MARKET FOR ORAL DRUG DELIVERY PRODUCTS

3.1 Controlled-Release Oral Drug Delivery Systems
	3.1.1 Diffusion-Controlled Systems
		3.1.1.1 Reservoir Systems
		3.1.1.2 Monolithic Systems
	3.1.2 Solvent-Activated Systems
		3.1.2.1 Hydrophilic Matrix Tablets
		3.1.2.2 Osmotically Controlled Systems
	3.1.3 Chemically Controlled Systems
		3.1.3.1 Biodegradable Systems
		3.1.3.2 Covalent Polymer-Drug Conjugate Systems
	3.1.4 Regulated Systems
		3.1.4.1 Magnetically Controlled Systems
		3.1.4.2 Ultrasound-Controlled Systems
		3.1.4.3 Orally Disintegrating Systems
	3.1.5 Closed-Loop Systems
	3.1.6 Multiparticulate Systems
	3.1.7 Advances in Oral Drug Delivery Technologies
		3.1.7.1 Prodrugs
		3.1.7.2 Pulsatile Systems
		3.1.7.3 Liposomes
3.2 Products and Technologies
3.3 Market Analysis
	3.3.1 Market Drivers
	3.3.2 Market Limiters
	3.3.3 Market Forecast
	3.3.4 Competitive Analysis

Exhibit 3-1: Advantages and Disadvantages of Controlled-Release Oral Drug Delivery Products
Exhibit 3-2: Reservoir-Based Diffusion-Controlled Drug Delivery
Exhibit 3-3: Advantages and Disadvantages of Reservoir-Based Diffusion-Controlled Drug Delivery Systems
Exhibit 3-4: Monolithic Diffusion-Controlled Drug Delivery
Exhibit 3-5: 2008, Selected Polymers Used in Matrix/Coating Oral Drug Delivery Products
Exhibit 3-6: OROS Osmotic Technology
Exhibit 3-7: Advantages of Osmotic Drug Delivery Systems
Exhibit 3-8: Ultrasound-Controlled Drug Delivery
Exhibit 3-9: Advantages of Orally Disintegrating Drug Delivery Systems
Exhibit 3-10: 2008, Selected Orally Disintegrating Drug Delivery Systems
Exhibit 3-11: Advantages and Disadvantages of Multiparticulate Drug Delivery Systems
Exhibit 3-12: 2008, Selected Types of Pulsatile Drug Delivery Systems
Exhibit 3-13: 2008, Selected Oral Drug Delivery Systems
Exhibit 3-14: Europe, Oral Drug Delivery Products, Market Forecast, by Country, 2007-2013
Exhibit 3-15: 2007, Europe, Oral Drug Delivery Products Market, Share by Supplier
Exhibit 3-16: 2007, France, Oral Drug Delivery Products Market, Share by Supplier
Exhibit 3-17: 2007, Germany, Oral Drug Delivery Products Market, Share by Supplier
Exhibit 3-18: 2007, Italy, Oral Drug Delivery Products Market, Share by Supplier
Exhibit 3-19: 2007, Spain, Oral Drug Delivery Products Market, Share by Supplier
Exhibit 3-20: 2007, United Kingdom, Oral Drug Delivery Products Market, Share by Supplier
Exhibit 3-21: 2007, Benelux Countries, Oral Drug Delivery Products Market, Share by Supplier
Exhibit 3-22: 2007, Nordic Countries, Oral Drug Delivery Products Market, Share by Supplier
Exhibit 3-23: 2007, Rest of Europe, Oral Drug Delivery Products Market, Share by Supplier

4. EUROPEAN MARKET FOR TRANSDERMAL DRUG DELIVERY PRODUCTS

4.1 Anatomy and Physiology of the Skin
4.2 Types of Transdermal Drug Delivery Systems
	4.2.1 Single-Layer Drug-in-Adhesive
	4.2.2 Multilayer Drug-in-Adhesive
	4.2.3 Reservoir
	4.2.4 Matrix
	4.2.5 Basic Components of Transdermal Drug Delivery Systems
		4.2.5.1 Backing Films
		4.2.5.2 Release Liners
		4.2.5.3 Pressure-Sensitive Adhesives
		4.2.5.4 Active Ingredient(s)
		4.2.5.5 Penetration Enhancers
		4.2.5.6 Semipermeable Membranes
		4.2.5.7 Pouching Materials
4.3 Technological Advances
	4.3.1 Chemical Permeation Enhancers
	4.3.2 Physical Permeation Enhancers
		4.3.2.1 Electrical Methods
			4.3.2.1.1 Electroporation
			4.3.2.1.2 Iontophoresis
		4.3.2.2 Mechanical Methods
			4.3.2.2.1 Abrasion
			4.3.2.2.2 Microneedle Puncture
			4.3.2.2.3 Needleless Injection
		4.3.2.3 Other Methods
			4.3.2.3.1 Laser and Photomechanical Waves
			4.3.2.3.2 Magnetophoresis
			4.3.2.3.3 Noninvasive Radiofrequency-Enhanced Drug Delivery
			4.3.2.3.4 Sonophoresis
			4.3.2.3.5 Thermal-Assisted Transdermal Drug Delivery
4.4 Products and Technologies
4.5 Market Analysis
	4.5.1 Market Drivers
	4.5.2 Market Limiters
	4.5.3 Market Forecast
	4.5.4 Competitive Analysis

Exhibit 4-1: Advantages and Disadvantages of Transdermal Drug Delivery
Exhibit 4-2: Anatomy of the Skin
Exhibit 4-3: Single-Layer Drug-in-Adhesive Transdermal Drug Delivery
Exhibit 4-4: Multilayer Drug-in-Adhesive Transdermal Drug Delivery
Exhibit 4-5: Reservoir Transdermal Drug Delivery
Exhibit 4-6: Matrix Transdermal Drug Delivery
Exhibit 4-7: Advantages and Disadvantages of Pressure-Sensitive Adhesives Used in Transdermal Drug Delivery Systems
Exhibit 4-8: Classification of Physical Permeation Enhancement Methods
Exhibit 4-9: Electroporation Enhancement of Transdermal Drug Delivery
Exhibit 4-10: Iontophoresis Enhancement of Transdermal Drug Delivery
Exhibit 4-11: Microneedle Delivery Devices for Transdermal Drug Delivery
Exhibit 4-12: PowderMed's Needleless Particle-Mediated Epidermal Delivery Device
Exhibit 4-13: Ultrasound-Enhanced Transdermal Drug Delivery
Exhibit 4-14: 2009, Selected Transdermal Drug Delivery Systems
Exhibit 4-15: 2007, Europe, Sales of Transdermal Drug Delivery Systems, by Segment
Exhibit 4-16: Europe, Transdermal Drug Delivery Systems, Market Forecast, by Country, 2007-2013
Exhibit 4-17: 2007, Europe, Transdermal Drug Delivery Systems Market, Share by Supplier
Exhibit 4-18: 2007, France, Transdermal Drug Delivery Systems Market, Share by Supplier
Exhibit 4-19: 2007, Germany, Transdermal Drug Delivery Systems Market, Share by Supplier
Exhibit 4-20: 2007, Italy, Transdermal Drug Delivery Systems Market, Share by Supplier
Exhibit 4-21: 2007, Spain, Transdermal Drug Delivery Systems Market, Share by Supplier
Exhibit 4-22: 2007, United Kingdom, Transdermal Drug Delivery Systems Market, Share by Supplier
Exhibit 4-23: 2007, Benelux Countries, Transdermal Drug Delivery Systems Market, Share by Supplier
Exhibit 4-24: 2007, Nordic Countries, Transdermal Drug Delivery Systems Market, Share by Supplier
Exhibit 4-25: 2007, Rest of Europe, Transdermal Drug Delivery  Systems Market, Share by Supplier

5. EUROPEAN MARKET FOR INHALATION DRUG DELIVERY PRODUCTS

5.1 Anatomy and Physiology of the Respiratory System
5.2 Physiochemical Principles in Inhalation Drug Delivery
5.3 Types of Inhalation Drug Delivery Systems
	5.3.1 Metered Dose Inhalers
	5.3.2 Dry Powder Inhalers
	5.3.3 Nebulizer Inhalers
	5.3.4 Liquid-Based Inhalers
	5.3.5 Emerging Developments
		5.3.5.1 Inhaled Gene Therapy
		5.3.5.2 Inhaled Liposomes
		5.3.5.3 Inhaled Systemic Drugs
		5.3.5.4 Inhaled Vaccines
		5.3.5.5 Piezo-Electronic Inhalers
5.4 Formulation Components
	5.4.1 Metered Dose Inhaler Formulation Components
		5.4.1.1 Solution Formulations
		5.4.1.2 Suspension Propellant Formulations
	5.4.2 Dry Powder Inhaler Formulation Components
		5.4.2.1 Adhesive Mixture Formulations
		5.4.2.2 Soft Spherical Pellet Formulations
5.5 Products and Technologies
5.6 Market Analysis
	5.6.1 Market Drivers
	5.6.2 Market Limiters
	5.6.3 Market Forecast, Metered Dose Inhalers
		5.6.3.1 Competitive Analysis
	5.6.4 Market Forecast, Dry Powder Inhalers
		5.6.4.1 Competitive Analysis
	5.6.5 Market Forecast, Nebulizer Inhalers
		5.6.5.1 Competitive Analysis
	5.6.6 Market Forecast, Liquid-Based Inhalers
		5.6.6.1 Competitive Analysis
	5.6.7 Combined Market Forecast
		5.6.7.1 Combined Competitive Analysis

Exhibit 5-1: Evolution of Pulmonary Drug Delivery Devices
Exhibit 5-2: Advantages of Pulmonary Drug Delivery
Exhibit 5-3: Simple Diagram of the Lung Structure
Exhibit 5-4: The Physiology of Gas Exchange
Exhibit 5-5: Advantages and Disadvantages of Pressurized Metered Dose Inhalers
Exhibit 5-6: Mechanism of a Pressurized Metered Dose Inhaler
Exhibit 5-7: Advantages and Disadvantages of Dry Powder Inhalers
Exhibit 5-8: Advantages and Disadvantages of Nebulizer Inhalers
Exhibit 5-9: Piezo-Electronic Inhaler Technology
Exhibit 5-10: 2009, Selected Metered Dose Inhalers
Exhibit 5-11: 2009, Selected Dry Powder Inhalers
Exhibit 5-12: 2009, Selected Nebulizer Inhalers
Exhibit 5-13: 2009, Selected Liquid-Based Inhalers
Exhibit 5-14: Europe, Metered Dose Inhalers, Market Forecast, by Country, 2007-2013
Exhibit 5-15: 2007, Europe, Metered Dose Inhalers Market, Share by Supplier
Exhibit 5-16: 2007, France, Metered Dose Inhalers Market, Share by Supplier
Exhibit 5-17: 2007, Germany, Metered Dose Inhalers Market, Share by Supplier
Exhibit 5-18: 2007, Italy, Metered Dose Inhalers Market, Share by Supplier
Exhibit 5-19: 2007, Spain, Metered Dose Inhalers Market, Share by Supplier
Exhibit 5-20: 2007, United Kingdom, Metered Dose Inhalers Market, Share by Supplier
Exhibit 5-21: 2007, Benelux Countries, Metered Dose Inhalers Market, Share by Supplier
Exhibit 5-22: 2007, Nordic Countries, Metered Dose Inhalers Market, Share by Supplier
Exhibit 5-23: 2007, Rest of Europe, Metered Dose Inhalers Market, Share by Supplier
Exhibit 5-24: Europe, Dry Powder Inhalers, Market Forecast, by Country, 2007-2013
Exhibit 5-25: 2007, Europe, Dry Powder Inhalers Market, Share by Supplier
Exhibit 5-26: 2007, France, Dry Powder Inhalers Market, Share by Supplier
Exhibit 5-27: 2007, Germany, Dry Powder Inhalers Market, Share by Supplier
Exhibit 5-28: 2007, Italy, Dry Powder Inhalers Market, Share by Supplier
Exhibit 5-29: 2007, Spain, Dry Powder Inhalers Market, Share by Supplier
Exhibit 5-30: 2007, United Kingdom, Dry Powder Inhalers Market, Share by Supplier
Exhibit 5-31: 2007, Benelux Countries, Dry Powder Inhalers Market, Share by Supplier
Exhibit 5-32: 2007, Nordic Countries, Dry Powder Inhalers Market, Share by Supplier
Exhibit 5-33: 2007, Rest of Europe, Dry Powder Inhalers Market, Share by Supplier
Exhibit 5-34: Europe, Nebulizer Inhalers, Market Forecast, by Country, 2007-2013
Exhibit 5-35: 2007, Europe, Nebulizer Inhalers Market, Share by Supplier
Exhibit 5-36: 2007, France, Nebulizer Inhalers Market, Share by Supplier
Exhibit 5-37: 2007, Germany, Nebulizer Inhalers Market, Share by Supplier
Exhibit 5-38: 2007, Italy, Nebulizer Inhalers Market, Share by Supplier
Exhibit 5-39: 2007, Spain, Nebulizer Inhalers Market, Share by Supplier
Exhibit 5-40: 2007, United Kingdom, Nebulizer Inhalers Market, Share by Supplier
Exhibit 5-41: 2007, Benelux Countries, Nebulizer Inhalers Market, Share by Supplier
Exhibit 5-42: 2007, Nordic Countries, Nebulizer Inhalers Market, Share by Supplier
Exhibit 5-43: 2007, Rest of Europe, Nebulizer Inhalers Market, Share by Supplier
Exhibit 5-44: Europe, Liquid-Based Inhalers, Market Forecast, by Country, 2007-2013
Exhibit 5-45: 2007, Europe, Liquid-Based Inhalers Market, Share by Supplier
Exhibit 5-46: 2007, France, Liquid-Based Inhalers Market, Share by Supplier
Exhibit 5-47: 2007, Germany, Liquid-Based Inhalers Market, Share by Supplier
Exhibit 5-48: 2007, Italy, Liquid-Based Inhalers Market, Share by Supplier
Exhibit 5-49: 2007, Spain, Liquid-Based Inhalers Market, Share by Supplier
Exhibit 5-50: 2007, United Kingdom, Liquid-Based Inhalers Market, Share by Supplier
Exhibit 5-51: 2007, Benelux Countries, Liquid-Based Inhalers Market, Share by Supplier
Exhibit 5-52: 2007, Nordic Countries, Liquid-Based Inhalers Market, Share by Supplier
Exhibit 5-53: 2007, Rest of Europe, Liquid-Based Inhalers Market, Share by Supplier
Exhibit 5-54: Europe, Sales of Inhalation Drug Delivery Products, by Market Segment, 2007 and 2013
Exhibit 5-55: Europe, Inhalation Drug Delivery Products, Combined Market Forecast, by Country, 2007-2013
Exhibit 5-56: 2007, Europe, Combined Inhalation Drug Delivery Products Market, Share by Supplier
Exhibit 5-57: 2007, France, Combined Inhalation Drug Delivery Products Market, Share by Supplier
Exhibit 5-58: 2007, Germany, Combined Inhalation Drug Delivery Products Market, Share by Supplier
Exhibit 5-59: 2007, Italy, Combined Inhalation Drug Delivery Products Market, Share by Supplier
Exhibit 5-60: 2007, Spain, Combined Inhalation Drug Delivery Products Market, Share by Supplier
Exhibit 5-61: 2007, United Kingdom, Combined Inhalation Drug Delivery Products Market, Share by Supplier
Exhibit 5-62: 2007, Benelux Countries, Combined Inhalation Drug Delivery Products Market, Share by Supplier
Exhibit 5-63: 2007, Nordic Countries, Combined Inhalation Drug Delivery Products Market, Share by Supplier
Exhibit 5-64: 2007, Rest of Europe, Combined Inhalation Drug Delivery Products Market, Share by Supplier

6. EUROPEAN MARKET FOR TRANSMUCOSAL DRUG DELIVERY PRODUCTS

6.1 Types
	6.1.1 Buccal and Sublingual Drug Delivery
	6.1.2 Nasal Drug Delivery
	6.1.3 Ocular Drug Delivery
		6.1.3.1 Liquids
		6.1.3.2 Solids
		6.1.3.3 Semisolids
		6.1.3.4 Other
	6.1.4 Vaginal Drug Delivery
6.2 Products and Technologies
6.3 Market Analysis
	6.3.1 Market Drivers
	6.3.2 Market Limiters
	6.3.3 Market Forecast
	6.3.4 Competitive Analysis

Exhibit 6-1: Advantages and Disadvantages of Nasal Drug Delivery
Exhibit 6-2: Advantages of Ocular Insert Drug Delivery
Exhibit 6-3: Advantages of Vaginal Drug Delivery
Exhibit 6-4: 2008, Selected Nasal Drug Delivery Products
Exhibit 6-5: 2008, Selected Buccal and Sublingual Drug Delivery Products
Exhibit 6-6: 2008, Selected Ocular Drug Delivery Products
Exhibit 6-7: 2008, Selected Vaginal Drug Delivery Products
Exhibit 6-8: Europe, Transmucosal Drug Delivery Products, Market Forecast, by Country, 2007-2013
Exhibit 6-9: 2007, Europe, Transmucosal Drug Delivery Products Market, Share by Supplier
Exhibit 6-10: 2007, France, Transmucosal Drug Delivery Products Market, Share by Supplier
Exhibit 6-11: 2007, Germany, Transmucosal Drug Delivery Products Market, Share by Supplier
Exhibit 6-12: 2007, Italy, Transmucosal Drug Delivery Products Market, Share by Supplier
Exhibit 6-13: 2007, Spain, Transmucosal Drug Delivery Products Market, Share by Supplier
Exhibit 6-14: 2007, United Kingdom, Transmucosal Drug Delivery Products Market, Share by Supplier
Exhibit 6-15: 2007, Benelux Countries, Transmucosal Drug Delivery Products Market, Share by Supplier
Exhibit 6-16: 2007, Nordic Countries, Transmucosal Drug Delivery Products Market, Share by Supplier
Exhibit 6-17: 2007, Rest of Europe, Transmucosal Drug Delivery Products Market, Share by Supplier

7. EUROPEAN MARKET FOR INJECTABLE DRUG DELIVERY PRODUCTS

7.1 Types of Injection Drug Delivery
	7.1.1 Intramuscular Injection
	7.1.2 Subcutaneous Injection
	7.1.3 Classification of Injection Devices
7.2 Types of Infusion Drug Delivery
	7.2.1 Intraoperative Site Infusion
	7.2.2 Intraspinal Infusion
	7.2.3 Intravenous Infusion
	7.2.4 External Infusion Pumps
		7.2.4.1 Gravity-Controlled Pumps
		7.2.4.2 Positive Displacement Pumps
			7.2.4.2.1 Volumetric Infusion Pumps
			7.2.4.2.2 Syringe Infusion Pumps
			7.2.4.2.3 Patient-Controlled Analgesia Infusion Pumps
			7.2.4.2.4 Ambulatory Pumps
			7.2.4.2.5 Disposable Infusion Pumps
	7.2.5 Implantable Infusion Pumps
7.3 Injection Drug Delivery, Products and Technologies
7.4 Infusion Drug Delivery, Products and Technologies
7.5 Market Analysis
	7.5.1 Market Drivers
	7.5.2 Market Limiters
	7.5.3 Market Forecast, Injection Drug Delivery Devices
		7.5.3.1 Competitive Analysis
	7.5.4 Market Forecast, Infusion Drug Delivery Products
		7.5.4.1 Competitive Analysis
	7.5.5 Combined Market Forecast
		7.5.5.1 Combined Competitive Analysis

Exhibit 7-1: Advantages and Disadvantages of Syringe Pumps
Exhibit 7-2: Advantages and Disadvantages of Patient-Controlled Analgesia Infusion Pumps
Exhibit 7-3: Advantages and Disadvantages of Disposable Infusion Pumps
Exhibit 7-4: 2009, Selected Disposable Safety Syringes
Exhibit 7-5: 2009, Selected Prefilled Syringes
Exhibit 7-6: 2009, Selected Insulin Pen Injectors
Exhibit 7-7: 2009, Selected Needle-Free Liquid Jet Injectors
Exhibit 7-8: 2009, Selected Hypodermic Needles and Syringes
Exhibit 7-9: 2009, Selected Insulin Infusion Pumps
Exhibit 7-10: 2009, Selected Syringe Infusion Pumps
Exhibit 7-11: 2009, Selected Volumetric Infusion Pumps
Exhibit 7-12: 2009, Selected Patient-Controlled Analgesia Infusion Pumps
Exhibit 7-13: 2009, Selected Ambulatory Infusion Pumps
Exhibit 7-14: 2009, Selected Constant-Flow Implantable Infusion Pumps
Exhibit 7-15: 2009, Selected Programmable Implantable Infusion Pumps
Exhibit 7-16: Europe, Injection Drug Delivery Products, Market Forecast, by Country, 2007-2013
Exhibit 7-17: 2007, Europe, Injection Drug Delivery Products Market, Share by Supplier
Exhibit 7-18: 2007, France, Injection Drug Delivery Products Market, Share by Supplier
Exhibit 7-19: 2007, Germany, Injection Drug Delivery Products Market, Share by Supplier
Exhibit 7-20: 2007, Italy, Injection Drug Delivery Products Market, Share by Supplier
Exhibit 7-21: 2007, Spain, Injection Drug Delivery Products Market, Share by Supplier
Exhibit 7-22: 2007, United Kingdom, Injection Drug Delivery Products Market, Share by Supplier
Exhibit 7-23: 2007, Benelux Countries, Injection Drug Delivery Products Market, Share by Supplier
Exhibit 7-24: 2007, Nordic Countries, Injection Drug Delivery Products Market, Share by Supplier
Exhibit 7-25: 2007, Rest of Europe, Injection Drug Delivery Products Market, Share by Supplier
Exhibit 7-26: Europe, Infusion Drug Delivery Products, Market Forecast, by Country, 2007-2013
Exhibit 7-27: 2007, Europe, Infusion Drug Delivery Products Market, Share by Supplier
Exhibit 7-28: 2007, France, Infusion Drug Delivery Products Market, Share by Supplier
Exhibit 7-29: 2007, Germany, Infusion Drug Delivery Products Market, Share by Supplier
Exhibit 7-30: 2007, Italy, Infusion Drug Delivery Products Market, Share by Supplier
Exhibit 7-31: 2007, Spain, Infusion Drug Delivery Products Market, Share by Supplier
Exhibit 7-32: 2007, United Kingdom, Infusion Drug Delivery Products Market, Share by Supplier
Exhibit 7-33: 2007, Benelux Countries, Infusion Drug Delivery Products Market, Share by Supplier
Exhibit 7-34: 2007, Nordic Countries, Infusion Drug Delivery Products Market, Share by Supplier
Exhibit 7-35: 2007, Rest of Europe, Infusion Drug Delivery Products Market, Share by Supplier
Exhibit 7-36: Europe, Injectable Drug Delivery Products, Combined Market Forecast, by Country, 2007-2013
Exhibit 7-37: 2007, Europe, Combined Injectable Drug Delivery Products Market, Share by Supplier
Exhibit 7-38: 2007, France, Combined Injectable Drug Delivery Products Market, Share by Supplier
Exhibit 7-39: 2007, Germany, Combined Injectable Drug Delivery Products Market, Share by Supplier
Exhibit 7-40: 2007, Italy, Combined Injectable Drug Delivery Products Market, Share by Supplier
Exhibit 7-41: 2007, Spain, Combined Injectable Drug Delivery Products Market, Share by Supplier
Exhibit 7-42: 2007, United Kingdom, Combined Injectable Drug Delivery Products Market, Share by Supplier
Exhibit 7-43: 2007, Benelux Countries, Combined Injectable Drug Delivery Products Market, Share by Supplier
Exhibit 7-44: 2007, Nordic Countries, Combined Injectable Drug Delivery Products Market, Share by Supplier
Exhibit 7-45: 2007, Rest of Europe, Combined Injectable Drug Delivery Products Market, Share by Supplier


8. COMPANY PROFILES

8.1 3M Health Care, Inc./3M Company
8.2 AstraZeneca PLC
8.3 Baxter International, Inc.
8.4 B. Braun Melsungen AG
8.5 Becton, Dickinson and Company
8.6 Biovail Corporation
8.7 Boehringer Ingelheim GmbH
8.8 Cardinal Health, Inc.
8.9 Elan Corporation PLC
8.10 Fresenius SE
8.11 GlaxoSmithKline PLC
8.12 Johnson & Johnson
8.13 Novartis AG
8.14 Noven Pharmaceuticals, Inc.
8.15 Terumo Europe NV/Terumo Corporation

APPENDIX: COMPANY LISTING


COMPANIES COVERED:

  1. 3M Health Care, Inc./3M Company
  2. AstraZeneca PLC
  3. Baxter International, Inc.
  4. B. Braun Melsungen AG
  5. Becton, Dickinson and Company
  6. Biovail Corporation
  7. Boehringer Ingelheim GmbH
  8. Cardinal Health, Inc.
  9. Elan Corporation PLC
  10. Fresenius SE
  11. GlaxoSmithKline PLC
  12. Johnson & Johnson
  13. Novartis AG
  14. Noven Pharmaceuticals, Inc.
  15. Terumo Europe NV/Terumo Corporation
Contact Us

Need help finding medtech research? Let us help you!